Mike Taylor

Mike Taylor

Formal First Name
Michael (Mike)

Michael Taylor is the Portfolio Manager of PINK, the first ETF committed to donating all net profits to the Susan G. Komen breast cancer organization. He is a renowned hedge fund investor with more than 20 years of investment experience in the healthcare and biotech sectors. He is a prominent scientist, virologist, and healthcare investor who is regarded to have built and run one of the best-performing healthcare funds on Wall Street. During this time, he worked in drug development and traded healthcare stocks.

Professional Experience

Academic History


  • Taylor began his career in 1995 as a scientist at GenVec, where he developed predominantly viral vector-based Gene Therapeutic Drugs for the BioPharma industry. 
  • He entered the investment industry in 2001 as the Head of Healthcare at OppenheimerFunds, where he oversaw the day-to-day operations, portfolio selection/trades, and research staff. 
  • From 2006 to 2011, he managed hedged and factor-neutral portfolios with a gross amount of over $1 billion at funds including Millennium, Citadel, and Diamondback Capital. 
  • Prior to PINK, he served as the Portfolio Manager and Managing Director of CriticalMass Partners, where he specialized in Healthcare Investing.


  • Taylor spoke at the 2020 Hedgeye Investing Summit.
  • He has appeared as a guest on Hedgeye TV multiple times.